Study finds examining retinal structure could provide markers for Parkinson disease

FHS
August 24, 2023
10:33 am

A new paper examined the retinal data from Parkinson disease patients in attempt to identify disease markers.

Natural Medicine Advisory Bulletin #4: September 2023 – Psychedelic Alpha

*** One new non-voting participant was introduced in the September meeting of the Qualifications, Licensing, and Training subcommittee. The new participant, Luke Priel, is a

November 1, 2023

Colorado DOR Natural Medicine Division Listening Sessions: Part 1 – Psychedelic Alpha

*** Listening Session #5 – Cultivation and Manufacturing Practices Part 1 Following formalities, Dominique Mendiola gave an overview of DOR’s statutory requirements under Title 44

November 1, 2023

The lessons of Aduhelm, Biogen’s Alzheimer’s drug that was not to be

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history. This week

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.